Abstract
Diabetes is an endemic global illness that is on the rise in both developed and developing countries. The American Diabetes Association has suggested glycated haemoglobin (HbA1c) as a possible substitute for fasting blood glucose in diagnosing diabetes. HbA1c is an important measure of long-term glycaemic control since it can represent the total glycaemic history of the two to three months before. In addition to providing a reliable measure of chronic hyperglycemia, HbA1c is highly correlated with the risk of long-term complications from diabetes. Elevated HbA1c has also been identified as an independent risk factor for coronary heart disease and stroke in people with or without diabetes. However, recent research has demonstrated that inadequate iron levels and glycemia contribute to high HbA1c.Therefore, decreasing circulating iron levels might be a worrying risk factor for heart attacks and strokes. The HbA1c test is an impartial biomarker for the diagnosis and outlook of diabetes since it offers valuable information with just one test. This studys results have demonstrated the significance of HbA1c in the diagnosis and prognosis of diabetic patients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call